🚀 VC round data is live in beta, check it out!

Institute of Biomedical Valuation Multiples

Discover revenue and EBITDA valuation multiples for Institute of Biomedical and similar public comparables like MetaVia, Genxone, Vivesto, ExpreS2ion Biotech and more.

Institute of Biomedical Overview

About Institute of Biomedical

Institute of Biomedical Research Corp is a biomedical research and development company. The company is focused on alternative plant-based food and medicine and mental health therapeutic research. The company uses brand name M2Bio Sciences engaged in deploying artificial intelligence, science and medicine, clinical research, and emerging technologies.


Founded

1990

HQ

United Arab Emirates

Employees

7

Website

m2bio.co

Financials (FY)

Revenue:
Net Income:

EV

$5M

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Institute of Biomedical Stock Performance

Institute of Biomedical has current market cap of $5M, and enterprise value of $5M.

Market Cap Evolution


Institute of Biomedical's stock price is $0.00.

See Institute of Biomedical trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$5M$5M0.0%XXXXXXXXX

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Institute of Biomedical Valuation Multiples

Institute of Biomedical Financial Valuation Multiples

As of March 11, 2026, Institute of Biomedical has market cap of $5M and EV of $5M.

Equity research analysts estimate Institute of Biomedical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$5MXXX$5MXXXXXXXXX
EV (current)$5MXXX$5MXXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Institute of Biomedical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Valuation Multiples Across 230+ Verticals

Institute of Biomedical Public Comps

See public comps and valuation multiples for other Biopharmaceuticals comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
MetaViaXXXXXXXXXXXXXXXXXX
GenxoneXXXXXXXXXXXXXXXXXX
VivestoXXXXXXXXXXXXXXXXXX
ExpreS2ion BiotechXXXXXXXXXXXXXXXXXX
AtonXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Institute of Biomedical M&A Activity

Institute of Biomedical acquired XXX companies to date.

Last acquisition by Institute of Biomedical was on XXXXXXXX, XXXXX. Institute of Biomedical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Institute of Biomedical

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Institute of Biomedical Investment Activity

Institute of Biomedical invested in XXX companies to date.

Institute of Biomedical made its latest investment on XXXXXXXX, XXXXX. Institute of Biomedical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Institute of Biomedical

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Institute of Biomedical

When was Institute of Biomedical founded?Institute of Biomedical was founded in 1990.
Where is Institute of Biomedical headquartered?Institute of Biomedical is headquartered in United Arab Emirates.
How many employees does Institute of Biomedical have?As of today, Institute of Biomedical has over 7 employees.
Is Institute of Biomedical publicly listed?Yes, Institute of Biomedical is a public company listed on OTC Pink Sheets.
What is the stock symbol of Institute of Biomedical?Institute of Biomedical trades under MRES ticker.
Who are competitors of Institute of Biomedical?Institute of Biomedical main competitors are MetaVia, Genxone, Vivesto, ExpreS2ion Biotech.
What is the current market cap of Institute of Biomedical?Institute of Biomedical's current market cap is $5M.
Is Institute of Biomedical profitable?No, Institute of Biomedical is not profitable.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial